3D Medical Image Segmentation for Quantitative Radiopharmaceutical Uptake

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical imaging processes for disease diagnosis, particularly prostate cancer, rely heavily on subjective human judgment, leading to inter- and intra-reader variability and inefficiencies, and patients struggle to understand treatment options and risks without proper communication of imaging results.

Innovation Solution

Automated analysis of 3D medical images using convolutional neural networks (CNNs) to identify specific organs and determine radiopharmaceutical uptake metrics, reducing subjectivity and improving accuracy and reproducibility by combining 3D anatomical and functional images, such as CT and SPECT, to provide quantitative measures of radiopharmaceutical uptake.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If automated analysis using CNNs is implemented, then measurement precision and reliability are improved, but device complexity increases

Engineering Contradiction:
Improveradiopharmaceutical uptake measurement precisionVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The automated analysis system is divided into distinct functional modules: a CNN-based segmentation module that identifies anatomical structures and a quantification module that calculates radiopharmaceutical uptake metrics. This segmentation allows each module to specialize in specific tasks, improving overall measurement precision while managing system complexity through modular design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary processing layer that bridges raw imaging data and clinical interpretation. The CNN-based automated analysis acts as an intermediary that transforms complex imaging data into standardized uptake metrics, reducing subjectivity while managing the complexity of direct human interpretation through algorithmic mediation.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If manual analysis by radiologists is used, then ease of operation is maintained, but productivity and measurement precision deteriorate due to inter- and intra-reader variability

Engineering Contradiction:
Improveoperational simplicityVSAvoidanalysis efficiency
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The system enables self-service automated analysis where the CNN-based algorithm independently performs segmentation and quantification without requiring manual intervention. This self-service capability eliminates inter- and intra-reader variability, improves measurement precision, and increases productivity while maintaining ease of operation through automated workflows.

Inventive Principle:
Principle #25Self-service

3Adaptability or versatility

If subjective human judgment is used in image analysis, then adaptability to complex cases is improved, but reliability and consistency deteriorate due to inter- and intra-reader variability

Engineering Contradiction:
Improveflexibility in case assessmentVSAvoidconsistency of results
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent transforms subjective visual assessment parameters into objective quantitative parameters through automated CNN-based analysis. By changing from subjective judgment parameters to standardized uptake metrics, the system improves reliability and consistency while maintaining adaptability through the ability to apply the same objective criteria across diverse clinical cases.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12602772B2Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
Publication Date: 2026.04.14 EXINI DIAGNOSTICS
  • US12602772B2 patent drawing
  • US12602772B2 patent drawing
  • US12602772B2 patent drawing

AI summary

Presented herein are systems and methods that provide for automated analysis of three-dimensional (3D) medical images of a subject in order to automatically identify specific 3D volumes within the 3D images that correspond to specific organs and/or tissue. In certain embodiments, the accurate identification of one or more such volumes can be used to determine quantitative metrics that measure uptake of radiopharmaceuticals in particular organs and/or tissue regions. These uptake metrics can be used to assess disease state in a subject, determine a prognosis for a subject, and/or determine efficacy of a treatment modality.